Evidence map›Paper›PMID 41861061›Full record

ArticleRespiration; international review of thoracic diseases2026

Towards Personalised Screening for Lung Cancer: A Sex-Stratified Approach in a Danish Cohort Integrating Pre-Diagnostic Systemic Inflammatory Indexes with Smoking Status and Age.

María Del Pilar Fernández Montejo, Uffe Bodtger, Randi Jepsen, Søren Lophaven, Ioannis Fotopoulos, Oluf Dimitri Røe, Zaigham Saghir

Abstract read
In one paragraph

Article in Respiration; international review of thoracic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

María Del Pilar Fernández MontejoCentre for Health Research, Zealand University Hospital, Nykøbing F., Nykøbing Falster, Denmark, mafer@regionsjaelland.dk.
Uffe BodtgerDepartment of Internal Medicine, Zealand University Hospital Roskilde, Roskilde, Denmark.
Randi JepsenCentre for Health Research, Zealand University Hospital, Nykøbing F., Nykøbing Falster, Denmark.
Søren LophavenSanos, Søborg, Denmark.
Ioannis FotopoulosDepartment of Computer Science, University of Crete, Voutes Campus, Heraklion, Greece.
Oluf Dimitri RøeDepartment of Clinical and Molecular Medicine, Norwegian University of Science and Technology-NTNU, Trondheim, Norway.
Zaigham SaghirDepartment of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSex disparities in lung cancer risk assessment may lead to inequities in screening eligibility. Criteria based on smoking history and age can underrepresent women. Systemic inflammatory indexes derived from routine blood tests are potential biomarkers in cancer risk assessment. We investigated the association between systemic inflammatory indexes and lung cancer risk, stratified by sex, in a Danish cohort.

methodsWe conducted a population-based cohort study using data from the Lolland-Falster Health Study (LOFUS) linked to the Danish Pathology Data Bank (Patobank). Participants aged 40-74 years without a history of lung cancer were included. We calculated four systemic inflammatory indexes and assessed their association with lung cancer using logistic regression models adjusted for age, sex, and smoking status. Optimal cut-off points were determined using the Youden index. Bootstrapping was applied for internal validation.

resultsAmong 10,887 participants with complete data, 58 (0.53%) were diagnosed with lung cancer during a maximum follow-up period of 6.6 years. High levels of all four inflammatory indexes were associated with increased lung cancer risk. Sex-stratified analyses revealed stronger associations between Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune Inflammatory Index (SII) and lung cancer in men, and between C-reactive protein to albumin ratio (CAR) and lung cancer in women. Model discrimination improved after adding inflammatory indexes.

conclusionOur findings support sex-specific lung cancer risk assessment and personalised screening strategies. Pre-diagnostic inflammatory indexes may serve as biomarkers to complement existing screening criteria. Further research is needed to validate their potential in improving lung cancer prediction models.

Indexed as

BiomarkersLolland-Falster Health StudyLung cancer screeningPersonalised medicineSex differencesSystemic inflammatory indexes

Identifiers

PMID41861061
PMCPMC13252921

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.